Catalyst Wire Dossier Catalyst Wire Dossier
CLINICAL_TRIALS research · 2025-07-14

Clinical Trial Update: Which of the Commonly Available and Approved Drugs in Addition to Standard of Care Can Significantly Improve the Slope of Estimated Glomerular Filtration Rate at Two Years When Compared to Standard of Care Alone in South-Asian Kidney Biopsy-proven Adult (≥18 Years) Primary IgA Nephropathy? [Phase 4]

View source ↗

Summary

A Phase 4 study in South Asia is evaluating whether adding any commonly available approved drugs to standard of care improves the two-year slope of estimated gl…

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

Snippet

Sponsor: Christian Medical College, Vellore, India | Conditions: IgA Nephropathy, Renal Insufficiency, Chronic | Phase 4 | Status: RECRUITING